Navigation Links
Reportlinker Adds What's Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015
Date:6/6/2011

ents (non-vaccine)Market, 2008-2015 Compound Annual Growth Rate

Figure 1-1 Global Biopharmaceutical Treatments (non-vaccine)Market, 2008-2015

CHAPTER TWO: INTRODUCTION

Table 2-1 World Cancer Incidence by Selected Types of Cancer, 2010 and 2020, all races, both sexes

Table 2-2 Total Cancer Incidence by Sex and Country, 2010 Estimates

Table 2-3 Phases of Clinical Drug Development in the United States

CHAPTER THREE: PRODUCT OVERVIEW

Table 3-1 Monoclonal Antibody Source Identifiers

Figure 3-1 Biopharmaceutical Approvals by Year Range (FDA)

Table 3-2 Select Biopharmaceutical Drugs Approved for Marketing

Table 3-2 (continued) Select Biopharmaceutical Drugs Approved for Marketing

Table 3-2 (continued) Select Biopharmaceutical Drugs Approved for Marketing

Table 3-2 (continued) Select Biopharmaceutical Drugs Approved for Marketing

Table 3-2 (continued) Select Biopharmaceutical Drugs Approved for Marketing

CHAPTER FOUR: DEVELOPMENTS

Figure 4-1 Biopharmaceutical Development by General Indication and Development Activity (Phase III through Registration)

Table 4-1 New Developments in Biopharmaceutical, Phase III and Beyond

Table 4-1 (continued) New Developments in Biopharmaceutical, Phase III and Beyond

Table 4-1 (continued) New Developments in Biopharmaceutical, Phase III and Beyond

Table 4-1 (continued) New Developments in Biopharmaceutical, Phase III and Beyond

Table 4-1 (continued) New Developments in Biopharmaceutical, Phase III and Beyond

Table 4-1 (continued) New Developments in Biopharmaceutical, Phase III and Beyond

Table 4-1 (continued) New Developments in Biopharmaceutical, Phase III and Beyond

Table 4-1 (continued) New Developments in Biopharmaceutical, Phase III and Beyond

Figure 4-2 Pipeline Snapshot: Biopharmaceutical Pipelines for New Compounds and Product Extensions by Type'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
2. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Proteomics: Technologies and Global Markets Report
5. Reportlinker Adds Nanomedicine Report
6. Reportlinker Adds Small Molecule Kinase Inhibitors Report
7. Reportlinker Adds Nanoporous Materials Report
8. Reportlinker Adds Membrane Bioreactors Report
9. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
10. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
11. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... GMO corn cases filed across the ... in the process of being consolidated in a Kansas ... In Re: Syngenta AG MIR 162 Corn Litigation, MDL ... District of Kansas. , Management of the Syngenta GMO ... U.S. District Judge John W. Lungstrum.* , As a ...
(Date:12/24/2014)... December 23, 2014 According to Ross Selinger, ... Affiliate of ITRA Global, the national office market continues to ... This is evidenced by the third quarter’s surprising 3.9% ... Low energy costs have held inflation down and the ... is the housing market remaining soft. , This solid economic ...
(Date:12/24/2014)... Diego, CA (PRWEB) December 23, 2014 ... where their Twitter followers can submit their #HolidayInTheLab ... themselves and their lab mates. , For those struggling ... lab mates, the Pipette.com Holiday in the Lab Contest ... Pipette.com Twitter followers to send pictures of ...
(Date:12/24/2014)... 2014 Sigma-Aldrich Corporation (NASDAQ: ... under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) ... 22, 2014, thereby completing the U.S. HSR Act ... of the Company by Merck KGaA, Darmstadt, Germany.  ... condition to closing the transaction, which remains subject ...
Breaking Biology Technology:Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3
... Recognized for Development of Statistical Methods and SoftwareSAN DIEGO, ... and of Health Research & Policy at Stanford ... Academy of Sciences. Election to the National Academy ... can be accorded to a scientist in the US ...
... published,today in the online edition of Nature Genetics, scientists ... from Iceland, Denmark and the,Netherlands present the discovery of ... (SNPs) that influence the age of girls at menarche, ... by both genetic,and environmental factors, though the SNPs reported ...
... naturally occurring elements, add another to the list of those ... physics in Arts & Sciences at Washington University in St. ... the time discovered that europium becomes superconducting at 1.8 ... making it the 53rd known elemental superconductor and the 23rd ...
Cached Biology Technology:Professor Wing Wong Elected to the National Academy of Sciences 2deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease 2deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease 3deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease 4Europium discovery 2Europium discovery 3
(Date:12/22/2014)... 22, 2014 Research and Markets ... addition of the "The Global Watermarking ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... overview of the global digital media watermarking ... and monitor piracy by securely and invisibly ...
(Date:12/19/2014)... 2014   LaunchKey , the first decentralized mobile ... Internet of Things era, today announced the close of ... was led by Metamorphic Ventures with participation from ENIAC ... and others.  LaunchKey has raised $4 million to date, ... team and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... addition of the "Global Chemical Sensor Market ... http://photos.prnewswire.com/prnh/20130307/600769 One ... increasing demand for medical sensors in biomedical applications. ... for quick and correct diagnosis during surgical procedures. ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... FORT COLLINS - In the last 50 years, modern ... of today,s veterinary and human medicine students still hone ... pig,s feet before transitioning to a live patient. An ... artificial body parts that look, feel, behave, and even ...
... been at least a billion years since plants and ... eons shared a common threat in the form of ... in remarkably similar mechanisms for detecting the molecular signatures ... treatment of infectious diseases in humans. The recognition ...
... produce many antibodies against the protein encapsulating the virus, most ... A new study suggests why some of the most common ... a form it takes after the virus has already invaded ... Hospital Boston and their colleagues. The findings, published ...
Cached Biology News:Invention helps students learn surgical techniques before operating on patients 2Reading the signs: Plants and animals found common ground in response to microbial threats 2Designing more effective anti-HIV antibodies 2Designing more effective anti-HIV antibodies 3